Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Katherine Kacena Consulting is a private biostatistics and clinical development consulting firm focused on drug, device, and diagnostic development. The business provides statistical support for clinical trial design, simulation, analysis, data monitoring committee statistics, and communications with regulators, patient groups, and investors. Its work spans development from preclinical through post-approval and covers therapeutic areas including oncology, cardiovascular disease, autoimmune disease, infectious disease, chronic pain, enzyme deficiencies, in vitro diagnostics, medical devices, and radiotherapeutics. The firm appears to be centered on the expertise of founder and principal statistical consultant Katherine Kacena rather than on an internal therapeutic product pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Katherine Kacena Consulting.